1. Home
  2. WTO vs GLTO Comparison

WTO vs GLTO Comparison

Compare WTO & GLTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WTO
  • GLTO
  • Stock Information
  • Founded
  • WTO 2008
  • GLTO 2011
  • Country
  • WTO China
  • GLTO Denmark
  • Employees
  • WTO N/A
  • GLTO N/A
  • Industry
  • WTO Consumer Electronics/Appliances
  • GLTO Biotechnology: Pharmaceutical Preparations
  • Sector
  • WTO Technology
  • GLTO Health Care
  • Exchange
  • WTO Nasdaq
  • GLTO Nasdaq
  • Market Cap
  • WTO 8.0M
  • GLTO 6.5M
  • IPO Year
  • WTO 2021
  • GLTO 2020
  • Fundamental
  • Price
  • WTO $0.27
  • GLTO $4.52
  • Analyst Decision
  • WTO
  • GLTO Buy
  • Analyst Count
  • WTO 0
  • GLTO 1
  • Target Price
  • WTO N/A
  • GLTO $10.00
  • AVG Volume (30 Days)
  • WTO 626.7K
  • GLTO 17.6K
  • Earning Date
  • WTO 02-24-2025
  • GLTO 03-07-2025
  • Dividend Yield
  • WTO N/A
  • GLTO N/A
  • EPS Growth
  • WTO N/A
  • GLTO N/A
  • EPS
  • WTO N/A
  • GLTO N/A
  • Revenue
  • WTO $32,309,502.00
  • GLTO N/A
  • Revenue This Year
  • WTO N/A
  • GLTO N/A
  • Revenue Next Year
  • WTO N/A
  • GLTO N/A
  • P/E Ratio
  • WTO N/A
  • GLTO N/A
  • Revenue Growth
  • WTO 47.36
  • GLTO N/A
  • 52 Week Low
  • WTO $0.25
  • GLTO $4.40
  • 52 Week High
  • WTO $59.25
  • GLTO $23.50
  • Technical
  • Relative Strength Index (RSI)
  • WTO 41.04
  • GLTO 40.56
  • Support Level
  • WTO $0.27
  • GLTO $4.50
  • Resistance Level
  • WTO $0.29
  • GLTO $5.25
  • Average True Range (ATR)
  • WTO 0.03
  • GLTO 0.34
  • MACD
  • WTO 0.00
  • GLTO -0.05
  • Stochastic Oscillator
  • WTO 15.75
  • GLTO 9.63

About WTO UTime Limited

UTime Ltd is engaged in the design, development, production, sales and brand operation of mobile phones, accessories and related consumer electronics. It also provides Electronics Manufacturing Services (EMS), including Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services, for renowned brands. The company operates in China and its products are sold globally, including Mexico, Brazil, the United States, and other emerging markets in South Asia and Africa as well as Europe. It has two in-house brands, UTime, known as its middle-to-high end label and targets middle class consumers from emerging markets; and Do, as its low- to mid-end brand, is positioned to the grassroots consumers and price-sensitive consumers in emerging markets.

About GLTO Galecto Inc.

Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of fibrosis and impact a broad range of fibrotic and related diseases, including cancer. Its initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, or LOXL2. Its product candidate GB0139 is for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, a life-threatening progressive fibrotic disease of the lung. Its product GB1211, a selective oral galectin-3 inhibitor for the treatment of fibrosis related to non-alcoholic steatohepatitis, or NASH, and GB2064, a selective oral inhibitor of LOXL2 that it initially plans to develop for the treatment of myelofibrosis.

Share on Social Networks: